135 related articles for article (PubMed ID: 6333369)
1. Leucocyte adherence inhibition assay for cell-mediated immunity and immunodiagnosis of pancreatic cancer.
Onji M
Gastroenterol Jpn; 1984 Aug; 19(4):328-35. PubMed ID: 6333369
[TBL] [Abstract][Full Text] [Related]
2. Microplate leucocyte adherence inhibition (LAI) assay in pancreatic cancer: detection of specific antitumor immunity with patients' peripheral blood cells and serum.
Goldrosen MH; Dasmahapatra K; Jenkins D; Howell JH; Arbuck SG; Moore MC; Douglass HO
Cancer; 1981 Mar; 47(6 Suppl):1614-9. PubMed ID: 6168355
[No Abstract] [Full Text] [Related]
3. A leukocyte adherence inhibition (LAI) assay of anti-tumor immunity in rats using selective radioimmunological assessment of adherence of T lymphocytes and monocytes.
Morizane T; Sjögren HO
Int J Cancer; 1983 Jun; 31(6):803-12. PubMed ID: 6345408
[TBL] [Abstract][Full Text] [Related]
4. Tube leukocyte adherence inhibition (LAI) assay in gastrointestinal (GIT) cancer.
Tataryn DN; MacFarlane JK; Murray D; Thomson DM
Cancer; 1979 Mar; 43(3):898-912. PubMed ID: 371789
[TBL] [Abstract][Full Text] [Related]
5. An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition.
Flores M; Marti JH; Grosser N; MacFarlane JK; Thomson DM
Cancer; 1977 Feb; 39(2):494-505. PubMed ID: 319891
[TBL] [Abstract][Full Text] [Related]
6. Leukocyte adherence inhibition to myelin basic protein by cancer patients' T-lymphocytes in association with class II major histocompatibility antigens on monocytes.
Thomson DM; Halliday WJ; Phelan K
J Natl Cancer Inst; 1985 Dec; 75(6):995-1003. PubMed ID: 2415744
[TBL] [Abstract][Full Text] [Related]
7. Cell-populations involved in the humoral leukocyte adherence inhibition reaction. The T8-suppressor/cytotoxic cells are both effectors and responders.
Moskaug JO; Kotlar HK; Sanner T
Eur J Cancer Clin Oncol; 1987 Feb; 23(2):149-56. PubMed ID: 2965016
[TBL] [Abstract][Full Text] [Related]
8. Detection of different states of immunity to colon cancer in rats by a leukocyte adherence inhibition (LAI) assay assessing the adherence of T lymphocytes and monocytes selectively.
Morizane T; Sjögren HO
Int J Cancer; 1983 Jun; 31(6):813-6. PubMed ID: 6345409
[TBL] [Abstract][Full Text] [Related]
9. Leucocyte adherence inhibition assay for immunodiagnosis of hepatocellular carcinoma.
Onji M
Gastroenterol Jpn; 1984 Aug; 19(4):336-43. PubMed ID: 6092190
[TBL] [Abstract][Full Text] [Related]
10. Blocking of the response by human T-lymphocytes to extracts of autologous cancer by monoclonal antibody to Class-I major histocompatibility complex gene products in the leukocyte adherence inhibition assay.
Shenouda G; Thomson DM
Cancer Res; 1984 Jul; 44(7):2762-8. PubMed ID: 6609766
[TBL] [Abstract][Full Text] [Related]
11. New micro-glass-tube leukocyte adherence inhibition assay assessing cell adherence of mononuclear cell subpopulations defined by monoclonal antibodies.
Morizane T; Satoh I; Kumagai N; Saito H; Iino A; Inagaki Y; Watanabe T; Tsuchimoto K; Tsuchiya M
J Immunol Methods; 1986 Jul; 91(2):225-9. PubMed ID: 3090150
[TBL] [Abstract][Full Text] [Related]
12. Selectivity of the micro-leukocyte adherence inhibition assay in pancreatic cancer.
Douglass HO; Russo AJ; Howell JH; Moore MC; Arbuck SG; Chu TM; Goldrosen MH
Cancer; 1979 Mar; 43(3):1084-8. PubMed ID: 371783
[TBL] [Abstract][Full Text] [Related]
13. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
[TBL] [Abstract][Full Text] [Related]
14. The role of the leukocyte adherence inhibition (LAI), CA 19-9, and tissue polypeptide antigen (TPA) tests in the diagnosis of pancreatic cancer.
Meduri F; Doni MG; Merenda R; Bizzarini M; Neri D; Gerunda GE; Maffei Faccioli A
Cancer; 1989 Sep; 64(5):1103-6. PubMed ID: 2667748
[TBL] [Abstract][Full Text] [Related]
15. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
Tsang PH; Holland JF; Bekesi JG
J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
[TBL] [Abstract][Full Text] [Related]
16. A computerized tube leukocyte adherence inhibition assay to detect antitumor immunity in early human cancer: a review of two years' experience.
Ayeni RO; Tataryn DN; MacFarlane JK; Thomson DM; Schwartz R
Surgery; 1980 Apr; 87(4):380-9. PubMed ID: 6989000
[TBL] [Abstract][Full Text] [Related]
17. [Leukocyte-adherence-inhibition reactivity in patients with colorectal and pancreatic cancer (author's transl)].
Wagner T; Peschel U; Heydrich D; Ritter U
Z Gastroenterol; 1981 Mar; 19(3):140-7. PubMed ID: 7234027
[TBL] [Abstract][Full Text] [Related]
18. Leucocyte adherence inhibition assay (LAI) in cancer of the oral cavity.
Prabha B; Kumary ; Vasudevan DM
Eur J Cancer Clin Oncol; 1984 Jul; 20(7):891-7. PubMed ID: 6540190
[TBL] [Abstract][Full Text] [Related]
19. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
Ludwig HJ; Storch H
Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755
[TBL] [Abstract][Full Text] [Related]
20. Leucocyte adherence inhibition for detecting specific tumour immunity in early pancreatic cancer.
Tataryn DN; MacFarlane JK; Thomson DM
Lancet; 1978 May; 1(8072):1020-2. PubMed ID: 76938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
